Table 10.

Venous thromboembolism study summary study

Outcome/exposure/study number	Study summary
Venous thromboembolism
10.1	One medium-sized 2018 Scandinavian study explored the effect of SGLT2i class vs. GLP-1RA for VTE [50]. This study showed a neutral association for VTE in the whole population (Sweden and Denmark, DNS), the maximally adjusted population with narrow CIs (Sweden-only, Table S22) and subgroup analysis (DNS)

CI confidence interval, DNS data not shown, GLP‐1RA glucagon-like peptide 1 receptor agonist, SGLT2i sodium–glucose co-transporter 2 inhibitor, VTE venous thromboembolism